German biotech BioNTech and US drugmaker Pfizer are beginning a pivotal global study to evaluate their lead COVID-19 vaccine candidate. If the study is successful, the companies could submit the vaccine for regulatory approval as early as October.
- German biotech BioNTech and U.S. drugmaker Pfizer Inc said on Monday they would begin a pivotal global study to evaluate their lead COVID-19 vaccine candidate.
Patients are each given two doses of the drugmakers’ vaccine to help boost immunity, so the first 100 million doses would vaccinate around 50 million people. “The initiation of the Phase 2/3 trial is a major step forward in our progress toward providing a potential vaccine to help fight the ongoing COVID-19 pandemic,” said Kathrin Jansen, head of vaccine research and development at Pfizer.
Pfizer has already has an agreement to sell 100 million doses of its vaccine to the U.S. government and give it the option to buy 500 million more. It is in talks with other governments, including the European Union, about similar deals.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
EU talks with Pfizer, Sanofi, J&J on Covid-19 vaccines hit snags: SourcesBRUSSELS (REUTERS) - European efforts to secure potential Covid-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment method and potential liability costs, three EU officials told Reuters.. Read more at straitstimes.com.
Read more »
Pfizer-BioNTech begin late-stage study of lead Covid-19 vaccine candidateNEW YORK (REUTERS) - German biotech BioNTech and US drugmaker Pfizer Inc said on Monday (July 27) they would begin a pivotal global study to evaluate their lead Covid-19 vaccine candidate.. Read more at straitstimes.com.
Read more »
EU talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags: SourcesEuropean efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment method ...
Read more »
Exclusive: EU talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags - sourcesEuropean efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment method ...
Read more »
Pfizer-BioNTech begin late-stage study of lead Covid-19 vaccine candidateNEW YORK (REUTERS) - German biotech BioNTech and US drugmaker Pfizer Inc said on Monday (July 27) they would begin a pivotal global study to evaluate their lead Covid-19 vaccine candidate.. Read more at straitstimes.com.
Read more »
Moderna's Covid-19 vaccine candidate moves into late-stage trialMASSACHUSETTS (REUTERS) - Moderna said on Monday (July 27) that it has started a US government-backed late-stage trial for its Covid-19 vaccine candidate, the first to be implemented under the Trump administration's Operation Warp Speed anti-coronavirus programme.. Read more at straitstimes.com.
Read more »